512 related articles for article (PubMed ID: 15016836)
1. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
Xiao Y; Kellar KJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
[TBL] [Abstract][Full Text] [Related]
2. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
4. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
Xiao Y; Baydyuk M; Wang HP; Davis HE; Kellar KJ
Bioorg Med Chem Lett; 2004 Apr; 14(8):1845-8. PubMed ID: 15050613
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
[TBL] [Abstract][Full Text] [Related]
7. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
Parker MJ; Beck A; Luetje CW
Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.
Avila AM; Dávila-García MI; Ascarrunz VS; Xiao Y; Kellar KJ
Mol Pharmacol; 2003 Oct; 64(4):974-86. PubMed ID: 14500754
[TBL] [Abstract][Full Text] [Related]
9. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
10. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
11. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells.
Warpman U; Friberg L; Gillespie A; Hellström-Lindahl E; Zhang X; Nordberg A
J Neurochem; 1998 May; 70(5):2028-37. PubMed ID: 9572289
[TBL] [Abstract][Full Text] [Related]
12. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
13. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
[TBL] [Abstract][Full Text] [Related]
14. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells.
Gorbounova O; Svensson AL; Jönsson P; Mousavi M; Miao H; Hellström-Lindahl E; Nordberg A
J Neurochem; 1998 Mar; 70(3):1134-42. PubMed ID: 9489734
[TBL] [Abstract][Full Text] [Related]
16. Developmental expression of heteromeric nicotinic receptor subtypes in chick retina.
Vailati S; Moretti M; Longhi R; Rovati GE; Clementi F; Gotti C
Mol Pharmacol; 2003 Jun; 63(6):1329-37. PubMed ID: 12761343
[TBL] [Abstract][Full Text] [Related]
17. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
[TBL] [Abstract][Full Text] [Related]
18. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity.
Lansdell SJ; Millar NS
Neuropharmacology; 2000 Feb; 39(4):671-9. PubMed ID: 10728888
[TBL] [Abstract][Full Text] [Related]
19. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
Nai Q; McIntosh JM; Margiotta JF
Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
[TBL] [Abstract][Full Text] [Related]
20. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
